• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Perrigo Company Public Limited Company (PRGO)

    -NYSE
    143.88 Down 0.23(0.16%) 4:02PM EST
    |After Hours : 143.85 Down 0.03 (0.02%) 5:30PM EST
    ProfileGet Profile for:
    Perrigo Company Public Limited Company
    Treasury Building
    Lower Grand Canal Street
    Dublin, 2
    Ireland - Map
    Phone: 353 1 709 4000
    Website: http://www.perrigo.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Related Products
    Full Time Employees:13,500

    Business Summary 

    Perrigo Company plc, through its subsidiaries, develops, manufactures, and markets over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx Pharmaceuticals), Specialty Sciences, and Other segments. The CHC segment offers OTC products, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, and other healthcare products, as well as vitamins, minerals, and dietary supplements; and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health; vitamins, minerals, and supplements; cough, cold, and allergy; personal care and derma-therapeutics; lifestyle; and anti-parasite areas. This segment serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx Pharmaceuticals segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment provides Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients that are used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Perrigo Company Public Limited Company

    Corporate Governance 
    Perrigo Company Public Limited Company’s ISS Governance QuickScore as of Feb 1, 2016 is 6. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 2; Compensation: 8.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Joseph C. Papa , 61
    Chairman and Chief Exec. Officer
    2.86M0.00
    Mr. John T. Hendrickson , 53
    Pres
    1.02M820.00K
    Ms. Judy L. Brown , 44
    Chief Financial Officer and Exec. VP
    1.21M1.10M
    Mr. Todd W. Kingma , 56
    Exec. VP, Gen. Counsel and Sec.
    905.00K576.00K
    Mr. Sharon Kochan , 48
    Exec. VP and Gen. Mang. of International
    857.00K352.00K
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders